Understanding Metrogyl
Metrogyl 400mg is a nitroimidazole antibiotic compound containing metronidazole as the active pharmaceutical ingredient, manufactured by J.B. Chemicals & Pharmaceuticals Ltd. This formulation enables researchers at Stroid UK Shop to investigate antimicrobial mechanisms, bacterial resistance patterns, and anaerobic metabolism pathways. Metronidazole demonstrates selective activity against anaerobic bacteria and certain protozoal organisms through its unique reduction-dependent mechanism of action. Laboratory studies frequently examine this compound’s cytotoxic effects when reduced by bacterial nitroreductases, making it valuable for research into selective antimicrobial targeting. The 400mg formulation provides consistent dosing for controlled experimental conditions across various research protocols.
Laboratory Applications
Research applications for Metrogyl 400mg span multiple areas of microbiological and pharmacological investigation. Scientists studying anaerobic bacterial cultures utilise this compound to examine selective growth inhibition and resistance development mechanisms. The formulation proves particularly valuable for researchers investigating Helicobacter pylori eradication protocols and combination therapy effectiveness. Studies examining DNA damage responses often incorporate metronidazole due to its interaction with cellular DNA repair pathways. Research into metronidazole and other pharmaceutical compounds frequently evaluates pharmacokinetic parameters and tissue distribution patterns. Additionally, investigators studying inflammatory bowel conditions examine this compound’s anti-inflammatory properties beyond its antimicrobial effects. The standardised 400mg formulation enables reproducible research outcomes across comparative studies, while researchers exploring combination therapies with selective androgen receptor modulators or bioactive peptides can establish controlled baseline protocols.
Product Specifications
| Active Ingredient | Metronidazole |
|---|---|
| Strength | 400mg per tablet |
| Manufacturer | J.B. Chemicals & Pharmaceuticals Ltd |
| CAS Number | 443-48-1 |
| Molecular Formula | C₆H₉N₃O₃ |
| Molecular Weight | 171.15 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Solubility | Sparingly soluble in water |
Research Compliance
This metronidazole formulation is supplied exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or any clinical application. Researchers must ensure proper laboratory safety protocols and waste disposal procedures when handling this pharmaceutical compound. All studies should comply with institutional research guidelines and appropriate regulatory frameworks governing antimicrobial research.
